| (210) | Number of the EPO application | 21719462 |
| (220) | Filing date of the EPO application | 2021.03.25 |
| (80) | EPO patent specification publication (B) | EPB nr. 46/2023, 2023.11.15 |
| (110) | EPO patent number | 4045533 |
| (21) | Number of the application | e 2022 0942 |
| (71) | Name(s) of applicant(s), code of the country | Vanderbilt University, US; |
| (72) | Name(s) of inventor(s), code of the country | CROWE James E. Jr., US;
ZOST Seth, US;
CARNAHAN Robert, US;
GILCHUK Pavlo, US; |
| (73) | Name(s) of owner(s), code of the country | Vanderbilt University, US; |
| (54) | Title of the invention | HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/10 (2006.01.01); G01N 33/569 (2006.01.01); G01N 33/577 (2006.01.01); A61K 39/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2022.09.30 |
| (30) | Priority | 202063000299 P, 2020.03.26, US; 202063002896 P, 2020.03.31, US; 202063003716 P, 2020.04.01, US; 202063023545 P, 2020.05.12, US; 202063024204 P, 2020.05.13, US; 202063024248 P, 2020.05.13, US; 202063027173 P, 2020.05.19, US; 202063037984 P, 2020.06.11, US; 202063040224 P, 2020.06.17, US; 202063040246 P, 2020.06.17, US; 202163142196 P, 2021.01.27, US; 202163161890 P, 2021.03.16, US |
| (86) | International application | PCT/US2021/024215, 2021.03.25 |
| (87) | International publication | WO 2021/195418, 2021.09.30 |